Chemo Patch to Treat Pancreatic Cancer With Fewer Side Effects

Chemotherapy is typically delivered by IV injection, leading to large amount of the poison reaching the healthy body while tumors don’t get a sufficient dose. Chemotherapy of the pancreas is particularly susceptible to this effect because pancreatic tumors are poorly vascularized, absorbing little of the drug compound. At MIT and Massachusetts General Hospital there’s work on an implantable patch that releases chemo drugs right at the site of treatment for pancreatic cancer patients that would have fewer side effects.

The investigators have already tested the patch on laboratory mice with pancreatic cancer, showing that the patch worked a dozen times better than traditional injections.


About Peter Coffaro 1134 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

1 Comment

Leave a Reply

Your email address will not be published.